VYNE Financials
Vyne Therapeutics Inc - Financial statements & key metrics
Stock Price
$28.56
Market Cap
$21.07M
P/E Ratio
-30.7
EPS
$-0.93
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$501,000
Gross Profit
-
Operating Income
-
Net Income
$-39.83M
EPS (Diluted)
$-0.93
Balance Sheet Highlights
Total Assets
$66.91M
Total Liabilities
$14.82M
Shareholders Equity
-
Cash & Equivalents
$19.93M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-33.97M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-7950.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is VYNE revenue?
VYNE's most recent quarterly revenue was $501,000. Annual revenue can be calculated by summing the four most recent quarters.
Is VYNE profitable?
VYNE reported a loss of $39.83M in the most recent quarter. The net profit margin is -7950.9%.
What is VYNE market cap?
VYNE has a market capitalization of $21.07M, making it a small-cap stock.
Does VYNE have debt?
View VYNE's balance sheet for debt information.
What is VYNE cash flow?
Cash flow data is available in the full financial statements.